Medindia

X

Irvine Celebrates 22 Years of Pharmaceutical Development Growth and Stability by Awarding Project Grants

Tuesday, April 13, 2010 General News J E 4
Advertisement

IRVINE, Calif., April 13 /PRNewswire/ -- Irvine Pharmaceutical Services, Inc., a premier pharmaceutical development and manufacturing organization, celebrates 22 years in business.  Founded in 1988, Irvine has grown into a full service pharmaceutical development provider located in Irvine, California, on a three-facility campus.

Irvine supports the pharmaceutical, biopharmaceutical, and medical device industries by providing GMP contract development and manufacturing services including formulation, analytical development, aseptic fill and finish, lyophilization, process validation, scale-up studies, packaging/labeling, stability storage and complete analytical CMC testing.

"Irvine’s steady growth, strength, and stability have allowed us to successfully expand to better support our clients' needs," said Dr. Assad J. Kazeminy, President and Founder of Irvine Pharmaceutical Services, Inc. "Irvine's latest service offerings include aseptic development and fill-and-finish manufacturing via its affiliate, Avrio Biopharma."

To celebrate 22 successful years, Irvine proudly offers 22 Anniversary Project Grants to thank the pharmaceutical community for their support. Visit www.irvinepharma.com/anniversary_grants.asp to learn about how your programs can benefit from Irvine's solid expansion and stability.

About Irvine

Irvine Pharmaceutical Services is a privately held, premier pharmaceutical development organization supporting the pharmaceutical, biopharmaceutical, and medical device industries. Together with its affiliate, Avrio Biopharma, Irvine offers cGMP contract development and manufacturing support including formulation, analytical development, aseptic fill and finish, lyophilization, process validation, scale-up studies, packaging/labeling, stability storage and complete analytical CMC testing. Visit www.irvinepharma.com or call 877-445-6554 to learn more.

SOURCE Irvine Pharmaceutical Services, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
RAM Founder to Receive 2010 Inamori Ethics Prize a...
S
Campaign for Better Care Ads Tell Lawmakers: The H...